Our finding that CD44 expression in normal intestinal epithelium and colon carcinomas is independent of p53 expression and p53 mutational status is of significance for understanding the pathogenesis of CRC and may have important therapeutic implications. The gene discussed is CD44; the disease is colorectal carcinoma.